DANIEL SALEVITZ
Pediatric Urology Physician in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: DANIEL SALEVITZ reported a CMS MIPS final score of 78.5864 out of 100, below the 83.1 national average, and filed 655 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
DANIEL SALEVITZ practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
DANIEL SALEVITZ at a glance
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Washington
How Pediatric Urology Physician compares to other specialties among Washington providers
Pediatric Urology Physician share within Washington
Pediatric Urology Physician is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DANIEL SALEVITZ's 2023 MIPS final score plotted against the Pediatric Urology Physician national average
- MIPS Final Score
- 78.5864/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Urology Physician) — 78.5864/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pediatric Urology Physician US NPIs
78.5864/100 MIPS final score — 4.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pediatric Urology Physician. Quality dim: 69.056. Cost dim: 59.5653.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DANIEL SALEVITZ is a Pediatric Urology Physician provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1740819796. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
DANIEL SALEVITZ appears in the CMS NPPES registry as a Pediatric Urology Physician provider at 4800 SAND POINT WAY NE, SEATTLE, WA, 98105, with a listed phone of (206) 987-0694. NPI 1740819796 was issued on 04/02/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SALEVITZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 655 prescription claims written by this provider, covering 322 Medicare beneficiaries and totaling roughly $56K in drug spend, with an opioid prescribing rate of 5.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.5864/100 for the 2023 performance year (Quality 69.056, Cost 59.5653), compared with the national average of 83.1.
Pediatric Urology Physician is a narrow specialty nationwide, with 348 enrolled providers across 43 states and an average of 654 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1740819796 |
|---|---|
| Specialty | Pediatric Urology Physician |
| Gender | Male |
| NPI Issued | 04/02/2020 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DANIEL SALEVITZ's current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where DANIEL SALEVITZ bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DANIEL SALEVITZ. Source: openpaymentsdata.cms.gov.
Total received
$507
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to DANIEL SALEVITZ. To verify DANIEL SALEVITZ's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,232
- Total Day Supply
- 30,194
- Generic Drug Cost
- $18K
- Opioid Claims
- 38 (5.8% rate)
- Antibiotic Claims
- 194
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.66
- Gender Split
- 25% female / 75% male
- Age Distribution
- <65: 19, 65-74: 154, 75-84: 123, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 167 |
| Finasteride | 55 |
| Cefdinir | 50 |
| Myrbetriq Mirabegron | 40 |
| Cephalexin | 33 |
| Oxycodone Hcl | 33 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 32 |
| Potassium Citrate Er Potassium Citrate | 22 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Urology Physician Overview
How DANIEL SALEVITZ fits within the Pediatric Urology Physician landscape nationally.
DANIEL SALEVITZ's 655 claims are above the specialty average of 654.
Nearby Pediatric Urology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as SALEVITZ.
Compare Pediatric Urology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is DANIEL SALEVITZ's specialty? ▼
How much does DANIEL SALEVITZ prescribe under Medicare Part D? ▼
What is DANIEL SALEVITZ's Medicare quality score? ▼
Where is DANIEL SALEVITZ located? ▼
What is DANIEL SALEVITZ's NPI number? ▼
Does DANIEL SALEVITZ prescribe opioids? ▼
How many Pediatric Urology Physician providers are there in the US? ▼
What drugs does DANIEL SALEVITZ prescribe most often? ▼
Does DANIEL SALEVITZ accept Medicare? ▼
How can I verify DANIEL SALEVITZ's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology